{"metadata":{"topics":["Accountability","Administrative law","Adverse effect","Advertising","Aggression","Antares","Anti-competitive behaviour","Applied ethics","Asset","Asset purchase agreement","Attorney's fee","Balance sheet","Bermuda","Business","Business economics","Business law","Canada","Chief executive officer","Civil law (common law)","Civil law (legal system)","Civil rights and liberties","Code of Federal Regulations","Cognition","Collective intelligence","Common law","Communication","Companies","Company","Comparative law","Competition","Competition (economics)","Complaint","Computer data","Computer law","Computer security","Computing","Confidentiality","Conflict (process)","Contract","Contract law","Copyright infringement","Corporate finance","Corporate governance","Corporate jargon","Corporate law","Corporate personhood","Corporations","Cost","Court","Criminal justice","Criminal law","Culture","Customer","Cyberspace","Data laws","Data processing","Dispute resolution","Document","Documents","Domain name","Drug","Drugs","Economic law","Economics of regulation","Economy","Economy of the United States","Environmental law","Environmental social science","Ethical principles","Ethically disputed business practices","Executive branch of the United States government","Expense","Externality","Facsimile","Fee","Finance","Financial accounting","Financial economics","Financial markets","Financial services","Financial statements","Food and Drug Administration","Generic drug","Good faith","Goodwill (accounting)","Government","Government agencies","Government and personhood","Government finances","Government information","Government institutions","Government of South Africa","Government of the United States","Health","Health policy","Healthcare industry","Human activities","Human communication","Human rights","Imperfect competition","Income statement","Indemnity","Industries","Information Age","Information science","Information technology","Intangible assets","Intellectual property","Intellectual property law","Intellectual works","Interest","Israel","Jargon","Judiciaries","Jurisprudence","Justice","Know-how","Law","Law and economics","Law of obligations","Lawsuit","Lawsuits","Lawyer","Leadership","Legal action","Legal concepts","Legal disputes","Legal doctrines and principles","Legal documents","Legal ethics","Legal fictions","Legal liability","Legal literature","Legal procedure","Legal writing","Legislative branch of the United States government","License","Licenses","Litigation strategy","Love","Management","Manufacturing","Market (economics)","Market failure","Marketing","Marketing plan","Microeconomics","Money","Monopoly (economics)","Morality","National security","Natural resources law","Number","Occupational safety and health","Official documents","Open government","Organization","Ownership","Packaging and labeling","Paragraph","Patent","Patent infringement","Patent law","Payment","Payments","Percentage","Personality traits","Pharmaceutical sciences","Pharmacology","Pharmacy","Pleading","Political economy","Political science","Politics","Politics and technology","Politics of the United States","Practice of law","Principles","Privacy","Privacy law","Private law","Product","Product liability","Production and manufacturing","Professional ethics","Property","Property law","Public administration","Public law","Public policy","Public records","Public sphere","Quantity","Receipt","Regulation","Regulation of technologies","Regulatory compliance","Reimbursement","Remainder","Rights","Royalty payment","Safety","Sales","Securities Exchange Act of 1934","Security","Security (finance)","Service industries","Services (economics)","Signature","Social information processing","Social institutions","Social issues","Sociological theories","Sources","South African law","Statutory law","Supply chain management","Surcharge (payment systems)","Tax","Technology","Telecommunications law","Trademark","U.S. Securities and Exchange Commission","Uniform Commercial Code","United States","United States Code","United States business law","United States dollar","United States economic policy","United States federal law","United States federal legislation","United States federal policy","United States intellectual property law","United States law","United States legislation","United States patent law","Urban, rural, and regional economics","Value (ethics)","Virtue","Witness","Writing","Written communication","environmental protection"],"person_names":["kevin insley","stephen m. simes"],"vars":{"Party":{"Hamilton":"[[Party 3]]","Azur Pharma International II Limited":"[[Party 2]]","BioSante Pharmaceuticals, Inc.":"[[Party 1]]"}},"organization_names":["ab","bpa","dpt","state","usd value","value"],"agreement_id":"eb95b281d53c0a8179579bd29a6b5b5ae0188ac0aa54f716728850abea0adef0","terms":["**AMENDMENT NO. 1 TO LICENSE AGREEMENT**","**AND ASSET PURCHASE AGREEMENT**","**After**","**Current**","**Event**","**Payment One**","**Payment Three A**","**Payment Three**","**Payment Two A**","**Payment Two**","**[Portions of this Exhibit have been omitted pursuant to a request for confidentiality under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A copy of this Exhibit with all sections intact has been filed separately with the Securities and Exchange Commission.]**","**[Portions of this Section have been omitted pursuant to a request for confidentiality under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. A copy of this Exhibit with all sections intact has been filed separately with the Securities and Exchange Commission.]**","*[signature page follows]*","*provided, however*","“**Amendment Effective Date**”","“**Amendment**”","“**Asset Purchase Agreement**”","“**BPA**”","“**Company**”","“**Infringement Claim**”","“**Infringement Suit**”","“**License Agreement**”","“**Parties**”","“**Party**”","“**Payment One**”","“**Payment Three A**”","“**Payment Three**”","“**Payment Two A**”","“**Payment Two**”","“In the event that one of more generic versions. . . .”"]}}